High dose therapy and autologous stem cell transplant does not improve survival compared with continued combination chemotherapy in people at high risk of relapse after initial treatment of advanced Hodgkin's lymphoma.
Reece
Donna E
DE
University Health Network, Princess Margaret Hospital, Toronto, Ont., Canada. donna.reece@uhn.on.ca
Sureda
Anna
A